HSD17B13 anticorps (AA 1-200)

N° du produit ABIN7868553

L’anticorps anti-HSD17B13 Monoclonal Souris est utilisé pour la détection de HSD17B13 dans des échantillons de Humain. Il a été validé pour IHC (p).

Aperçu rapide pour HSD17B13 anticorps (AA 1-200) (ABIN7868553)

Antigène: HSD17B13 (Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp HSD17B13 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: HSD17B13-13108

Détail du produit anti-HSD17B13 anticorps

Épitope: AA 1-200

Fonction: Hydroxysteroid 17-beta dehydrogenase 13 Antibody / HSD17B13

Purification: Protein G affinity

Immunogène: A portion of amino acids 1-200 of the human protein was used as the immunogen for the Hydroxysteroid 17-beta dehydrogenase 13 antibody.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the Hydroxysteroid 17-beta dehydrogenase 13 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the Hydroxysteroid 17-beta dehydrogenase 13 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur HSD17B13

Antigène: HSD17B13 (Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13))

Autre désignation: Hydroxysteroid 17-beta dehydrogenase 13

Sujet: Hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) is an engyme in the liver that is associated with lipid droplets. It is encoded by the HSD17B13 gene in humans. HSD17B13 levels increase in patients with non-alcoholic fatty liver disease (NAFLD) and can enhance lipogenesis. However, some studies have shown that loss-of-function variants in HSD17B13 may protect against the progression of NAFLD to non-alcoholic steatohepatitis, fibrosis, and hepatocellular carcinoma.

UniProt: Q7Z5P4